Market Research Logo

Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2016

The Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2016 report provides comprehensive understanding and unprecedented access to the personalized medicine in oncology partnering agreements entered into by the worlds leading companies.

Comprehensive directory of personalized medicine in oncology deals since 2010
Personalized medicine in oncology contract documents
Personalized medicine in oncology agreement terms
Personalized medicine in oncology agreement structure
Top personalized medicine in oncology deals by value
Most active personalized medicine in oncology dealmakers

The Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2016 report provides comprehensive understanding and unprecedented access to the personalized medicine in oncology partnering agreements entered into by the worlds leading healthcare companies.

The report provides a detailed understanding and analysis of how and why companies enter personalized medicine in oncology partnering deals. The majority of deals are discovery stage whereby the licensee obtains a right or an option right to license the licensors personalized medicine technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

The initial chapters of this report provide an orientation of Personalized Medicine in Oncology dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in Personalized Medicine in Oncology dealmaking since 2010, including details of average headline, upfront, milestone and royalty terms.

Chapter 3 provides a review of the leading Personalized Medicine in Oncology deals since 2010. Deals are listed by headline value, signed by big pharma, most active Personalized Medicine in Oncology dealmaking companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in Personalized Medicine in Oncology dealmaking with a brief summary followed by a comprehensive listing of Personalized Medicine in Oncology deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

Chapter 5 provides a comprehensive and detailed review of Personalized Medicine in Oncology partnering deals signed and announced since Jan 2010, where a contract document is available in the public domain. The chapter is organized by company A-Z, deal type (collaborative R&D, co-promotion, licensing etc), and specific therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Chapter 7 provides a comprehensive and detailed review of Personalized Medicine in Oncology partnering deals signed and announced since Jan 2010. The chapter is organized by specific Personalized Medicine in Oncology technology type in focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided organized by Personalized Medicine in Oncology partnering company A-Z, deal type definitions and Personalized Medicine in Oncology partnering agreements example. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Personalized Medicine in Oncology partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Personalized Medicine in Oncology technologies and products.

Report scope

Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2016 is intended to provide the reader with an in-depth understanding of the personalized medicine in oncology trends and structure of deals entered into by leading companies worldwide.

Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2016 includes:

Trends in personalized medicine in oncology dealmaking in the biopharma industry since 2010
Analysis of personalized medicine in oncology deal structure
Case studies of real-life personalized medicine in oncology deals
Access to over 700 personalized medicine in oncology deals
The leading personalized medicine in oncology deals by value since 2010
Most active personalized medicine in oncology dealmakers since 2010
The leading personalized medicine in oncology partnering resources

In Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2016, the available contracts are listed by:

Headline value
Stage of development at signing
Deal component type
Specific therapy target
Specific technology target

Each deal title links via Weblink to online deal records of actual personalized medicine in oncology partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.


  • Executive Summary
  • Introduction
  • Trends in Personalized Medicine in Oncology dealmaking
    • Introduction
    • Personalized Medicine in Oncology partnering over the years
    • Most active Personalized Medicine in Oncology dealmakers
    • Personalized Medicine in Oncology partnering by deal type
    • Personalized Medicine in Oncology partnering by therapy area
    • Deal terms for Personalized Medicine in Oncology partnering
      • Personalized Medicine in Oncology partnering headline values
        • Table Personalized Medicine in Oncology deals with a headline value
      • Personalized Medicine in Oncology deal upfront payments
        • Table Personalized Medicine in Oncology deals with an upfront value
      • Personalized Medicine in Oncology deal milestone payments
        • Table Personalized Medicine in Oncology deals with a milestone value
      • Personalized Medicine in Oncology royalty rates
        • Table Personalized Medicine in Oncology deals with a royalty rate value
  • Leading Personalized Medicine in Oncology deals
    • Introduction
    • Top Personalized Medicine in Oncology deals by value
      • Table Top Personalized Medicine in Oncology deals by value since 2010
  • Most active Personalized Medicine in Oncology dealmakers
    • Introduction
    • Most active Personalized Medicine in Oncology dealmakers
    • Most active Personalized Medicine in Oncology partnering company profiles
      • National Cancer Institute
      • Qiagen
      • Ventana Medical Systems
      • AstraZeneca
      • Dako
      • MD Anderson Cancer Center
      • Foundation Medicine
      • LUNGevity Foundation
      • Pfizer
      • Myriad Genetics
      • Cancer Genetics
      • Insight Genetics
      • Horizon Discovery
      • Roche
      • TrovaGene
      • Abbott Laboratories
      • Dana-Farber Cancer Institute
      • Epigenomics
      • Merck and Co
      • Rosetta Genomics
      • Biocept
      • Exosome Diagnostics
      • Federal Ministry of Education and Research (BMBF)
      • Johns Hopkins University
      • Massachusetts General Hospital
      • MDxHealth
      • National Institutes of Health
      • Novartis
      • Arno Therapeutics
      • Astellas Pharma
      • Asuragen
      • Cell Signaling Technology
      • Clarient
      • Clovis Oncology
      • GlaxoSmithKline
      • HTG Molecular Diagnostics
      • MolecularMD
      • NanoString Technologies
      • Quest Diagnostics
      • Response Genetics
      • Yale University
      • Abcodia
      • Amgen
      • Array Biopharma
      • Biocartis
      • Celgene
      • Debiopharm
      • Eisai
      • Eli Lilly
      • ImaginAb
  • Personalized Medicine in Oncology contracts dealmaking directory
    • Introduction
    • Personalized Medicine in Oncology contracts dealmaking directory
  • Personalized Medicine in Oncology dealmaking by technology type
    • Biomarkers
      • Companion
      • Personalised medicine
      • Pharmacogenomics
  • Partnering resource center
    • Online partnering
    • Partnering events
    • Further reading on dealmaking
  • Appendices
    • Appendix 1 - Personalized Medicine in Oncology deals by company A-Z
      • 20/20 GeneSystems
      • A*STAR Bioprocessing Technology Institute
      • A*STAR Genome Institute of Singapore
      • Abbott Laboratories
      • Abbott Molecular
      • Abbvie
      • Abcodia
      • AB Science
      • Accelerate Brain Cancer Cure
      • Accuri Cytometers
      • Accu Reference Medical Laboratory
      • Acobiom
      • Acorn Research
      • Activartis Biotech
      • Active Biotech
      • Activiomics
      • Adamis Pharmaceuticals
      • Adaptive Biotechnologies
      • Admera Health
      • Advanced Cell Diagnostics
      • Advaxis
      • Advinus Therapeutics
      • Aelan Cell Technologies
      • AEterna Zentaris
      • Affymetrix
      • Agendia
      • Agenus Bio
      • Agilent Technologies
      • Akrivis Technologies
      • Albert Einstein College of Medicine
      • Algeta
      • Alion Pharmaceuticals
      • Almac Diagnostics
      • Almac Group
      • AltheaDX
      • Amarantus BioSciences
      • Amarna Therapeutics
      • American Association for Cancer Research
      • American Red Cross
      • American Society of Clinical Oncology (ASCO)
      • Amgen
      • AmorChem
      • Amoy Diagnostics
      • Anam Hospital
      • Angle
      • Antitope
      • AOP Orphan Pharmaceuticals
      • Apceth
      • Apocell
      • Apogenix
      • Aptiv Solutions
      • Arctic Partners
      • Ariadne Genomics
      • Ariad Pharmaceuticals
      • Ariana Pharma
      • Arizona State University
      • Arno Therapeutics
      • Arrayit
      • Arrayit Diagnostics
      • Array Biopharma
      • Ascenta Therapeutics
      • Assistance Publique-Hôpitaux de Paris
      • Astellas Pharma
      • Astex Pharmaceuticals
      • AstraZeneca
      • Astrimmune
      • Asuragen
      • Athena Breast Health Network
      • Atlantic Cancer Research Institute
      • Atossa Genetics
      • Aushon BioSystems
      • Australian Research Council
      • Austrian Institute of Technology
      • Avantra Biosciences
      • Avaxia Biologics
      • AVEO Oncology
      • Avera Heart Hospital of South Dakota
      • Avila Therapeutics
      • Bavarian Nordic
      • Bayer
      • Bayer Healthcare
      • Baylor College of Medicine
      • BBVA Foundation
      • BC Cancer Agency
      • Beaujon Hospital
      • Beckman Coulter
      • Becton Dickinson
      • BeiGene
      • Beijing Genomics Institute (BGI)
      • Berg
      • Berg Pharma
      • Berkshire Medical Center
      • Beth Israel Deaconess Medical Center
      • BGI Tech Solutions
      • Bio-Rad Laboratories
      • Biocare Medical
      • Biocartis
      • Biocept
      • BioChain
      • Biodesix
      • BioDiscovery
      • BioFocus
      • Biofortis
      • Biognosys
      • Biohit
      • BioImagene
      • Biomarcare
      • BioMarin Pharmaceutical
      • BioMarker Strategies
      • Biomatrica
      • Biomerica
      • BioMerieux
      • Biomiga Diagnostics
      • Biomoda
      • Biopsy Sciences
      • BioReference Laboratories
      • BioSeek
      • BioTime
      • BioVendor
      • BioView
      • Bio Reference Laboratories
      • Bird Foundation
      • Blue Cross Blue Shield Association
      • Boehringer Ingelheim
      • Bonnie J. Addario Lung Cancer Foundation
      • Bostwick Laboratories
      • Boulder Diagnostics
      • Breast Cancer Research Foundation (BCRF)
      • Brigham and Women's Hospital
      • Bristol-Myers Squibb
      • Broad Institute
      • Bruker Daltonics
      • Buck Institute for Age Research
      • California Stem Cell
      • Caliper Life Sciences
      • Cambridge Biomedical
      • Canary Foundation
      • CANbridge Life Sciences
      • CancerGuide Diagnostics
      • Cancer Genetics
      • Cancer Genetics India
      • Cancer Immunotherapy Trials Network
      • Cancer Prevention and Research Institute of Texas
      • Cancer Research Society
      • Cancer Research Technology
      • Cancer Research UK
      • Cancer Targeted Technology
      • Cancer Treatment Centers of America
      • Cantonal Hospital
      • CanTX
      • Caris Life Sciences
      • Carmel Medical Center
      • Carolinas Medical Center (CMC)
      • Case Western Reserve University
      • Catholic Health Initiatives
      • Catholic University Leuven
      • CBLPath
      • CDx Diagnostics
      • Cedars-Sinai Medical Center
      • Celgene
      • Celldex Therapeutics
      • Cell Signaling Technology
      • Cenix BioScience
      • Center for Biomarker Research in Medicine
      • Center for Prostate Disease Research
      • Centocor Ortho Biotech
      • Centre for Drug Research and Development (CDRD)
      • Centre for Imaging Technology Commercialization
      • Centre Hospital University - Bordeaux
      • Centre Leon Berard
      • Centre National de la Recherche Scientifique
      • Cephalon
      • Cepheid
      • Cernostics
      • Champions Oncology
      • Children's Healthcare of Atlanta
      • Children's Hospital Los Angeles
      • Chronix Biomedical
      • Chugai Pharmaceutical
      • Chungnam National University
      • Clarient
      • Clavis Pharma
      • Clevexel Pharma
      • Clinical Genomics
      • Clinical Reference Laboratory
      • Cloud Pharmaceuticals
      • Clovis Oncology
      • CollabRx
      • Columbia University
      • Columbia University Medical Center
      • CombiMatrix
      • CompanDX
      • Companion Dx Reference Lab
      • Compendia Bioscience
      • Connecticut Children's Medical Center
      • Core Oncology
      • Corgenix Medical
      • Cornell University
      • Correlogic Systems
      • Courtagen Life Sciences
      • Covance
      • CSIRO
      • CureHealth Diagnostics
      • Cure Forward
      • Curie-Cancer
      • Curis
      • CvergenX
      • Cyclacel Pharmaceuticals
      • Cylene Pharma
      • Cynvenio
      • Daiichi Sankyo
      • Dako
      • Dana-Farber Cancer Institute
      • Danish National Advanced Technology Foundation
      • Debiopharm
      • DeCODE Genetics
      • Definiens
      • Denator
      • Denovo Biopharma
      • Department of Defense
      • DermaGenoma
      • Devicor Medical Products
      • DiagnoCure
      • DNA Therapeutics
      • Dr. Susan Love Research Foundation
      • Duke-NUS Graduate Medical School Singapore
      • Duke University
      • Duke University Medical Center
      • DxS
      • Dyax
      • Edith Sanford Breast Cancer Foundation
      • EDP Biotech
      • Eisai
      • EKF Diagnostics
      • Eli Lilly
      • EMD Millipore
      • EMD Serono
      • Emory University
      • Empire Genomics
      • Endocyte
      • Enlyten Medical Technologies
      • Enzo Biochem
      • Epic Sciences
      • Epigenomics
      • Epitomics
      • Epizyme
      • Erasmus University Medical Center
      • Erytech
      • Ethicon Endo-Surgery
      • Eureka Eurostars
      • Eurogentec
      • European Union
      • European Union Regional Development Fund
      • Eurotrans-Bio
      • Eutropics Pharmaceuticals
      • Evotec
      • Exactis Innovation
      • Exact Sciences
      • EXINI Diagnostics
      • ExonHit Therapeutics
      • Exosome Diagnostics
      • Expression Analysis
      • Ezose Sciences
      • F-Star
      • F-Star Alpha
      • Falco
      • Federal Ministry of Education and Research (BMBF)
      • Feist-Weiller Cancer Center
      • Fisher Healthcare
      • Five3 Genomics
      • Flatiron Health
      • Flemish agency for Innovation by Science and Technology
      • Fluidigm
      • Fluxion Biosciences
      • Fortified Provider Network
      • Foundation for the National Institutes of Health (FNIH)
      • Foundation Medicine
      • Foundation Venture Capital Group
      • Fox Chase Cancer Center
      • Fraunhofer Institute for Cell Therapy and Immunology
      • Fred Hutchinson Cancer Research Center
      • Freshmedx
      • Fudan University
      • Fujirebio Diagnostics
      • G-TAC
      • Gachon University
      • Galena Biopharma
      • Gallus Biopharmaceuticals
      • Garvan Institute of Medical Research
      • Geisinger Health System
      • Gen-Probe
      • Genalyte
      • GeneAssess
      • GeneCell
      • GeneDiagnostics
      • Genekor
      • GeneNews
      • Genentech
      • Genetic Technologies
      • Genewiz
      • Genmab
      • GenomeDx
      • Genomeon
      • Genome Institute of Singapore
      • Genomic Expression
      • Genomic Health
      • Genoptix
      • GenWay Biotech
      • Genzyme
      • Georges Francois Leclerc Center
      • Georgetown University Hospital
      • German Cancer Research Center
      • Gestion Univalor
      • GE Global Research
      • GE Healthcare
      • Gilead Sciences
      • GlaxoSmithKline
      • GlaxoSmithKline Biologicals
      • Global Discovery Biosciences
      • Gloval Specimen Solutions
      • Glycotest
      • GNS Healthcare
      • Gold Standard Diagnostics
      • Government of Germany
      • Gritstone Oncology
      • Guardant Health
      • GVK Biosciences
      • H3 Biomedicine
      • Hackensack University Medical Center
      • Hadasit Bioholdings
      • HalioDx
      • Halozyme Therapeutics
      • HALO Healthcare
      • Hartford Hospital
      • HealthLinx
      • Health Diagnostics Laboratory
      • Health Discovery
      • Hefei Medicine
      • Helmholtz Institute in Saarbrucken
      • Henry M. Jackson Foundation
      • Hirosaki University
      • HistoRx
      • Hologic
      • Horizon
      • Horizon 2020
      • Horizon Discovery
      • Hospital del Mar
      • Hospital of University of Strasbourg
      • HTG Molecular Diagnostics
      • Hybrigenics
      • IBM
      • Icahn School of Medicine at Mount Sinai
      • Idera Pharmaceuticals
      • Illumina
      • ImaginAb
      • Immune Design
      • ImmunID Technologies
      • ImmunoGen
      • IncellDx
      • Incyte
      • Indivumed
      • Inform Genomics
      • Innate Pharma
      • Inserm
      • Inserm Transfert
      • Insight Genetics
      • Institute for Hepatitis and Virus Research
      • Institute for Molecular Medicine Finland
      • Institute for Research in Immunology and Cancer - Commercialization of Research
      • Institute of Cancer Research
      • Institut Curie
      • Institut Gustave Roussy
      • IntegraGen
      • Intel
      • International Cancer Genome Consortium
      • International Genomics Consortium
      • International Health Technology
      • Interpace Diagnostics
      • Interpace Diagnostics Group
      • Intomics
      • Invivis Pharmaceuticals
      • InVivoScribe
      • Ionis Pharmaceuticals
      • IPMD
      • Ipsen
      • Ipsogen
      • IPS Genomix
      • IRCCS
      • IRIS International
      • IROA Technologies
      • Ironwood Pharmaceuticals
      • IRX Therapeutics
      • ISIS Innovation
      • Israeli National Authority for Technological Innovation
      • Jackson Laboratory
      • Janssen Biotech
      • Janssen Pharmaceuticals
      • Janssen Research & Development
      • Jiangsu Hengrui Medicine
      • Jinfiniti Biosciences
      • Johnson & Johnson
      • Johnson & Johnson Innovation
      • Johns Hopkins Kimmel Cancer Center
      • Johns Hopkins University
      • John Wayne Cancer Institute
      • Kadmon Pharmaceuticals
      • Kairos Therapeutics
      • Kalgene Pharmaceuticals
      • Keck School of Medicine of USC
      • Kindstar Globalgene Technology
      • KineMed
      • Kite Pharma
      • Knight Diagnostic Laboratories
      • Kreatech
      • Kymab
      • Kyto Biopharma
      • Lab21
      • Labcyte
      • LabMD
      • Laboratory Corporation of America
      • Lankenau Institute for Medical Research
      • Lantern Pharma
      • Lee Moffitt Cancer Center
      • Leica Biosystems
      • Leica Microsystems
      • Leukemia & Lymphoma Society
      • Life Technologies
      • Life Technologies Corporation
      • London Genetics
      • Lorus Therapeutics
      • Ludwig-Maximilians University
      • Luminex
      • Lumiphore
      • LUNGevity Foundation
      • M2Gen
      • M3
      • Macquarie University
      • Macrogen
      • Macrogenics
      • Maisonneuve-Rosemont Hospital (HMR)
      • Manhattan Scientifics
      • Mary Crowley Cancer Research Center
      • Massachusetts General Hospital
      • Massachusetts Institute of Technology
      • Massachusetts Life Sciences Center
      • Matrix-Bio
      • Mayo Clinic
      • McKesson
      • MDxHealth
      • MD Anderson Cancer Center
      • Medco Health Solutions
      • MEDIAN Technologies
      • Medical College of Georgia
      • Medical Prognosis Institute
      • Medical Research Council
      • MedImmune
      • Medinnova
      • Medivation
      • MedTrust Online
      • Med BioGene
      • Med fusion
      • Melanoma Diagnostic
      • Melanoma Research Foundation
      • Memorial Sloan Kettering Cancer Center
      • Merck and Co
      • Merck KGaA
      • Merck Serono
      • Merck Sharpe & Dohme
      • Merrimack Pharmaceuticals
      • Merus
      • Metamark Genetics
      • MetaStat
      • Methodist Hospital Research Institute
      • Millennium
      • Millennium Medical Devices
      • Miraculins
      • Mirati Therapeutics
      • Mira Dx
      • MirImmune
      • Mitomics
      • MolecularMD
      • Molecular Medicine Research Institute
      • Molecular Response
      • Montefiore Medical Center
      • Moores Cancer Center
      • Morphisto
      • MorphoSys
      • Morphotek
      • Movember Foundation
      • Multimmune
      • MultiPlan
      • Multiple Myeloma Research Foundation
      • Mundipharma
      • Munich Leukemia Laboratory
      • Myriad Genetics
      • N-of-One
      • NanoString Technologies
      • National Cancer Center of South Korea
      • National Cancer Centre Singapore
      • National Cancer Institute
      • National Cancer Research Institute
      • National Cheng Kung University
      • National Foundation for Cancer Research
      • National Healthcare Services (NHS)
      • National Institutes of Health
      • Nektar Therapeutics
      • Nemucore Medical Innovations
      • Neogenix Oncology
      • Neogenomics
      • NeoloMed BioSciences
      • Neon Therapeutics
      • NEO New Oncology
      • Netherlands Cancer Institute
      • NetScientific
      • NewBridge Pharmaceuticals
      • Newcastle University
      • NewVac
      • New Brunswick Health Research Foundation
      • New England Peptide (NEP)
      • New Liberty Proteomics
      • New York University
      • NextBio
      • NextGxDx
      • Nicholas Conor Institute for Pediatric Cancer Research
      • Nihon Medi-Physics
      • NimbleGen Systems
      • NMI Natural and Medical Sciences Institute
      • Noble Life Sciences
      • Northwestern Medicine Developmental Therapeutics Institute
      • Northwestern University
      • Northwest Biotherapeutics
      • Novartis
      • NovioGendix
      • Novogen
      • Nuclea Biotechnologies
      • NuView Life Sciences
      • OcellO
      • Ohio State University
      • Olink Bioscience
      • Omnyx
      • On-Q-ity
      • Oncgnostics
      • Oncimmune
      • Oncimmune Ltd
      • OncoCyte
      • Oncodesign
      • Oncomatrix
      • OncoMed Pharmaceuticals
      • OncoMethylome
      • OncoSec Medical
      • OncoSpire Genomics
      • Oncotest
      • Ono Pharmaceutical
      • Ontario Cancer Biomarker Network
      • Ontario Institute for Cancer Research
      • Onyx Pharmaceuticals
      • OPKO Health
      • Oragenics
      • Oregon Health Sciences University
      • Oridis Biomarkers
      • OSEO
      • OSI Pharmaceuticals
      • Oslo University Hospital
      • Otsuka
      • OvaGene Oncology
      • Oxford BioMedica
      • Oxford Cancer Biomarkers
      • Oxford Gene Technology
      • OxOnc Development
      • Pancreatic Cancer Action Network
      • Paradigm
      • Paris Descartes University
      • Parsortix
      • Paterson Institute for Cancer Research
      • Pathway Genomics
      • Pathwork Diagnostics
      • Patrys
      • Peking University Cancer Hospital
      • Penn State Hershey
      • PerkinElmer
      • Perseis Therapeutics
      • PersonalizeDx
      • Personal Genome Diagnostics
      • Perthera
      • Perugia University
      • Pervasis Therapeutics
      • Pfizer
      • PGXL Technologies
      • Pharmacyclics
      • PharmaMar
      • Pharmatech Oncology
      • Pharmatest Services
      • Pharmsynthez
      • Photocure ASA
      • Pieris
      • Pierre Fabre
      • Pikamab
      • Polymedco
      • Power3 Medical Products
      • PPD
      • Precision Antibody
      • Precision Therapeutics
      • Predictive Biomarker Sciences
      • PRIMA BioMed
      • Primeradx
      • Progenics Pharmaceuticals
      • PrognosDx Health
      • Promega
      • Pronto Diagnostics
      • Prostate Cancer Foundation (PCF)
      • Protagen
      • Protein Biotechnologies
      • Proteome Sciences
      • Providence Cancer Center
      • Provista Diagnostics
      • PTC Therapeutics
      • Purdue Research Foundation
      • Purdue University
      • QDx Pathology Services
      • Qiagen
      • QMDx Asia
      • Qualcomm
      • Quanticel Pharmaceuticals
      • QuantumDx
      • Quest Diagnostics
      • Quintiles
      • R-Biopharm
      • Radient Pharmaceuticals
      • RayBiotech
      • Regional Cancer Institute of Montpellier
      • Research Foundation of State University of New York
      • Research Institute of the Hospital Universitari Vall d'Hebron
      • Respira Health
      • Response Genetics
      • Revalesio
      • RiboMed
      • Roche
      • Roche Diagnostics
      • Roche Molecular Systems
      • Roche Servicios
      • Rosetta Genomics
      • Royal Marsden Hospital
      • Royal Philips Electronics
      • RT Oncology Services
      • Runbio Biotech
      • Rush University Medical Center
      • RXi Pharmaceuticals
      • Saccomanno Research Institute
      • Sachsische Aufbau Bank
      • Sage Bionetworks
      • SAIC-Frederick
      • Saladax Biomedical
      • Salix Pharmaceuticals
      • Samsung Medical Center
      • Sanofi-Aventis
      • Sanofi
      • San Raffaele Scientific Institute
      • Sarah Cannon Research Institute
      • Scancell
      • SciClone Pharmaceuticals
      • Scienion
      • ScreenCell
      • Scripps Genomic Medicine
      • Scripps Health
      • Scripps Research Institute
      • Scripps Translational Science Institute
      • SDIX
      • Seattle Genetics
      • Seegene
      • Selventa
      • Sengenics
      • Seoul Clinical Laboratories
      • Seoul National University Bundang Hospital
      • Serametrix
      • Servier
      • Shanghai Institute of Materia Medica
      • Shuwen Biotech
      • Side-Out Foundation
      • Siemens Healthcare
      • Signalchem
      • Signal Genetics
      • Signature Diagnostics
      • Silicon Biosystems
      • Siloam Biosciences
      • Singlera Genomics
      • Skyline Diagnostics
      • Small Business Innovation Research
      • SolaranRx
      • Soligenix
      • Solulink
      • Source Bioscience
      • South Texas Blood & Tissue Center
      • Sphingotec
      • Stanford University
      • Stanford University School of Medecine
      • START (South Texas Accelerated Research Therapeutics)
      • Statewide Clinical Trials Network of Texas
      • STC.UNM
      • Stratose
      • Stroke Detection Plus
      • Sunnybrook Health Sciences Centre
      • Surrey Cancer Research Institute
      • Sydys Corporation
      • Syndax Pharmaceuticals
      • Synergie Lyon Cancer
      • Synthon
      • Syros Pharmaceuticals
      • Sysmex Inostics
      • T-Ray Science
      • Taconic Biosciences
      • Taiho
      • Takeda Pharmaceutical
      • Targos
      • Technology Strategy Board (UK)
      • Technology Transfer Accelerator
      • Tel Hashomer
      • Tesaro
      • Teva Pharmaceutical Industries
      • Texas Oncology
      • Texas Scottish Rite Hospital for Children
      • TGen Drug Development
      • Theradiag
      • Theragenics
      • Theranostics Health
      • Therasis
      • Thermo Fisher Scientific
      • The Biomarker Factory
      • The Fleury Group
      • The Regents of the University of California
      • Thomas Jefferson University
      • Three Rivers Provider Network
      • Threshold Pharmaceuticals
      • Thrombotech
      • Tiziana Life Sciences
      • TMRC
      • Tocagen
      • Tokai Pharmaceuticals
      • Tolero Pharmaceuticals
      • Toulouse University Hospital
      • TRACON Pharmaceuticals
      • Transgene
      • Transgenic Operative Products
      • Transgenomic
      • Translational Genomics Research Institute
      • TrovaGene
      • TTFactor
      • UE LifeSciences
      • UK Biobank
      • UK Government
      • UK NEQAS
      • Unibioscreen
      • UNICANCER
      • Uniformed Services University of the Health Sciences
      • United States Biological
      • University College London
      • University Gottingen
      • University Health Network
      • University of Bergen
      • University of Bonn
      • University of California, Davis
      • University of California, San Diego
      • University of California
      • University of California Irvine
      • University of California Los Angeles
      • University of California San Francisco
      • University of Colorado Denver
      • University of Copenhagen
      • University of Florida
      • University of Illinois
      • University of Kansas
      • University of Massachusetts
      • University of Michigan
      • University of Minnesota
      • University of Montreal
      • University of Nebraska
      • University of North Dakota
      • University of North Texas Health Science Center
      • University of Oslo
      • University of Oxford
      • University of Pennsylvania
      • University of Pennsylvania School of Veterinary Medicine
      • University of Pittsburgh
      • University of Pittsburgh Cancer Institute
      • University of Rochester
      • University of Southern California
      • University of Stuttgart
      • University of Surrey
      • University of Texas
      • University of Texas Southwestern Medical Center
      • University of Tokyo
      • University of Washington
      • University of Wisconsin Carbone Cancer Center (UWCCC)
      • University of Wurzburg
      • USBiomarkers
      • USCN Life Science
      • US Oncology Research
      • ValiRx
      • Vancouver Prostate Centre
      • Vanderbilt-Ingram Cancer Center
      • Vanderbilt University
      • Van Andel Institute
      • Van Andel Research Institute
      • Vector Oncology
      • Ventana Medical Systems
      • Veracyte
      • Verastem
      • Veridex
      • Vermillion
      • Versant Ventures
      • VIB
      • Virax
      • Virginia Polytechnic Institute and State University
      • ViroMed
      • VirtualScopics
      • VolitionRX
      • VuCOMP
      • WaferGen Biosystems
      • Warnex Medical Laboratories
      • Washington University in St Louis
      • Wayne State University
      • Weill Cornell Medical College
      • Wellcome Trust
      • Whitehead Institute
      • Wilex
      • Wilex USA
      • Winship Cancer Institute
      • Wistar Institute
      • Worldwide Innovative Network (WIN) in personalized cancer medicine Consortium
      • WuXi PharmaTech
      • Yale University
      • Zymeworks
    • Appendix 2 - Personalized Medicine in Oncology deals by stage of development
      • Discovery
      • Preclinical
      • Phase I
      • Phase II
      • Phase III
      • Regulatory
      • Marketed
    • Appendix 3 - Personalized Medicine in Oncology deals by deal type
      • Asset purchase
      • Bigpharma outlicensing
      • Co-development
      • Collaborative R&D
      • Co-market
      • Co-promotion
      • CRADA
      • Development
      • Distribution
      • Equity purchase
      • Evaluation
      • Grant
      • Joint venture
      • Licensing
      • Manufacturing
      • Marketing
      • Option
      • Promotion
      • Research
      • Spin out
      • Sub-license
      • Supply
      • Technology transfer
      • Termination
    • Appendix 4 - Personalized Medicine in Oncology deals by therapy area
      • Oncology
      • Basal cell carcinoma
      • Bladder cancer
      • Bone cancer
      • Brain cancer
      • Breast cancer
      • Cervical cancer
      • Colorectal cancer
      • Endometrial
      • Esophageal cancer
      • Gastric cancer
      • Head and neck cancer
      • Kidney cancer
      • Leukemia
      • Acute lymphoblastic leukemia
      • Acute myelogenous leukemia
      • Chronic lymphocytic leukemia
      • Chronic myelogenous leukemia
      • Liver cancer
      • Lung cancer
      • Non small cell lung cancer
      • Lymphoma
      • Non Hodgkin's lymphoma
      • Melanoma
      • Mesothelioma
      • Metastases
      • Multiple myeloma
      • Ovarian cancer
      • Pancreatic cancer
      • Prostate cancer
      • Renal cell carcinoma
      • Sarcoma
      • Solid tumors
      • Symptoms
      • Oral mucositis
      • Testicular cancer
      • Thyroid cancer
    • Appendix 5 -Deal type definitions
  • About Wildwood Ventures
    • Current Partnering
    • Current Agreements
    • Recent report titles from Current Partnering

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report